X-67545316-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP3BP6_Very_StrongBS2

The NM_000044.6(AR):​c.216_239dupGCAGCAGCAGCAGCAGCAGCAGCA​(p.Gln73_Gln80dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q80Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0035 ( 7 hom., 13 hem., cov: 0)
Exomes 𝑓: 0.0013 ( 0 hom. 75 hem. )
Failed GnomAD Quality Control

Consequence

AR
NM_000044.6 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.337

Publications

10 publications found
Variant links:
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
AR Gene-Disease associations (from GenCC):
  • androgen insensitivity syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • Kennedy disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • partial androgen insensitivity syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • complete androgen insensitivity syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_000044.6
BP6
Variant X-67545316-T-TGCAGCAGCAGCAGCAGCAGCAGCA is Benign according to our data. Variant chrX-67545316-T-TGCAGCAGCAGCAGCAGCAGCAGCA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 464794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 7 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARNM_000044.6 linkc.216_239dupGCAGCAGCAGCAGCAGCAGCAGCA p.Gln73_Gln80dup disruptive_inframe_insertion Exon 1 of 8 ENST00000374690.9 NP_000035.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARENST00000374690.9 linkc.216_239dupGCAGCAGCAGCAGCAGCAGCAGCA p.Gln73_Gln80dup disruptive_inframe_insertion Exon 1 of 8 1 NM_000044.6 ENSP00000363822.3 P10275-1

Frequencies

GnomAD3 genomes
AF:
0.00347
AC:
231
AN:
66631
Hom.:
7
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00149
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00459
Gnomad ASJ
AF:
0.0227
Gnomad EAS
AF:
0.00432
Gnomad SAS
AF:
0.00548
Gnomad FIN
AF:
0.00346
Gnomad MID
AF:
0.00654
Gnomad NFE
AF:
0.00337
Gnomad OTH
AF:
0.00249
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00132
AC:
1232
AN:
936378
Hom.:
0
Cov.:
40
AF XY:
0.000255
AC XY:
75
AN XY:
294596
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000631
AC:
15
AN:
23753
American (AMR)
AF:
0.00201
AC:
52
AN:
25823
Ashkenazi Jewish (ASJ)
AF:
0.00884
AC:
143
AN:
16184
East Asian (EAS)
AF:
0.00396
AC:
112
AN:
28294
South Asian (SAS)
AF:
0.00164
AC:
74
AN:
45095
European-Finnish (FIN)
AF:
0.00279
AC:
101
AN:
36149
Middle Eastern (MID)
AF:
0.00116
AC:
3
AN:
2594
European-Non Finnish (NFE)
AF:
0.000896
AC:
644
AN:
718635
Other (OTH)
AF:
0.00221
AC:
88
AN:
39851
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.352
Heterozygous variant carriers
0
61
122
184
245
306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00345
AC:
230
AN:
66618
Hom.:
7
Cov.:
0
AF XY:
0.00157
AC XY:
13
AN XY:
8258
show subpopulations
African (AFR)
AF:
0.00149
AC:
28
AN:
18797
American (AMR)
AF:
0.00458
AC:
24
AN:
5236
Ashkenazi Jewish (ASJ)
AF:
0.0227
AC:
39
AN:
1715
East Asian (EAS)
AF:
0.00434
AC:
8
AN:
1843
South Asian (SAS)
AF:
0.00555
AC:
5
AN:
901
European-Finnish (FIN)
AF:
0.00346
AC:
7
AN:
2025
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
133
European-Non Finnish (NFE)
AF:
0.00337
AC:
117
AN:
34710
Other (OTH)
AF:
0.00246
AC:
2
AN:
812
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.535
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
237
Bravo
AF:
0.0000416

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Oct 31, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.34
Mutation Taster
=69/31
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3032358; hg19: chrX-66765158; API